FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
6,779,768
Share change
+46,257
Total reported value
$127,575,593
Price per share
$16.79
Number of holders
41
Value change
+$777,000
Number of buys
2

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q4 2013

As of 31 Dec 2013, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,779,768 shares. The largest 10 holders included HealthCor Management, L.P., TPG Group Holdings (SBS) Advisors, Inc., WELLINGTON MANAGEMENT CO LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, GOLDMAN SACHS GROUP INC, BVF INC/IL, FRANKLIN RESOURCES INC, MARXE AUSTIN W & GREENHOUSE DAVID M, PUTNAM INVESTMENTS LLC, and BlackRock Fund Advisors. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.